Scholarly article on tri-O-benzoyl-DL-threonic acid amide 3255-72-9 from Journal of the American Chemical Society p. 1091,1094

DOI: 10.1021/ja01235a009

Source and publish data:

Journal of the American Chemical Society p. 1091,1094 (1944)

Update date:2022-07-29

Topics:

Authors:

Lake Lake

Glattfeld

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1021/ja01235a009

Full text of DOI:10.1021/ja01235a009

Products guided by the article

Product name:tri-O-benzoyl-DL-threonic acid amide

Cas No:3255-72-9

R&D Labs maybe for 3255-72-9

Jiangsu King Road New Materials Co., Ltd.

website:http://www.jskingroad.com

Contact:0519-85720726 0519-85720721 15006126856

Address:No.1,Weihua Road,Xinbei District,Changzhou City,Jiangsu Province
Chengdu Green Young Biopharmaceutical INC

Contact:+86-28-85337952

Address:1-B-26,Tianhe Industry Park, No.1480 of Tianfu Road,Chengdu,P.R.China,610000
Changsha Easchem Co.,Limited

website:http://www.easchem.com

Contact:+86-731-89722861 89722891

Address:2/F-4/Bld Colorful Palace, No.605 Changsha Ave, Yuhua Area Changsha Hunan China.
Hangzhou Sartort Biopharma Co., Ltd

website:http://www.sartort.com

Contact:86-571-87039693

Address:No. 57, Tech Park Road, Hangzhou, Zhejiang, China
Cangzhou Senary Chemical Science-tech Co., Ltd

Contact:+86-317-3563899, 3563699

Address:168 Jinde Road, Cangzhou, Hebei, China

Relevant to this article

The convenient Michael addition of imidazoles to acrylates catalyzed by Lipozyme TL im from: Thermomyces lanuginosus in a continuous flow microreactor

Doi:10.1039/c8ob02533a
(2019)
Doi:10.1021/jm00288a018
(1971)
Total synthesis of (+)-crocacin C

Doi:10.1016/S0040-4020(01)00940-1
(2001)
New synthetic strategy for chiral 2-oxazolidinones derivatives via rhodium-catalyzed asymmetric hydrogenation

Doi:10.1016/j.tetlet.2015.12.105
(2016)
Synthesis of analogs of the ergot alkaloids

Doi:10.1002/jhet.5570370614
(2000)
Discovery of 1-(4-(4-Amino-3-(4-(2-morpholinoethoxy)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)phenyl)-3-(5-(tert-butyl)isoxazol-3-yl)urea (CHMFL-FLT3-213) as a Highly Potent Type II FLT3 Kinase Inhibitor Capable of Overcoming a Variety of FLT3 Kinase Mutan

Doi:10.1021/acs.jmedchem.7b00840
(2017)

Article Doi

DOI: 10.1021/ja01235a009